LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
24.34
-1.95 (-7.42%)
At close: Apr 10, 2026, 4:00 PM EDT
24.57
+0.23 (0.94%)
After-hours: Apr 10, 2026, 4:55 PM EDT
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $615.78 million as of April 10, 2026.
Market Cap
615.78M
Enterprise Value
324.14M
1-Year Change
n/a
Ranking
Category
Stock Price
$24.34
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $615.78M, an increase of 104.24%. That is a compound annual growth rate of 243.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 615.78M | 9.34% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 663.08M |
| Forte Biosciences | 658.58M |
| Alpha Tau Medical | 641.59M |
| Prime Medicine | 607.38M |
| Crescent Biopharma | 603.50M |
| Ocugen | 594.70M |
| ProKidney | 588.74M |
| Tectonic Therapeutic | 576.82M |